AVEO PHARMACEUTICALS INC's ticker is AVEO and the CUSIP is 053588307. A total of 57 filers reported holding AVEO PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.56 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $737 | -99.9% | 49,299 | -67.4% | 0.00% | -100.0% |
| Q3 2022 | $1,245,000 | -70.5% | 151,317 | -76.5% | 0.00% | -66.7% |
| Q2 2022 | $4,220,000 | -36.6% | 643,250 | -46.0% | 0.00% | 0.0% |
| Q1 2022 | $6,652,000 | +57.6% | 1,190,104 | +32.2% | 0.00% | +50.0% |
| Q4 2021 | $4,221,000 | -2.6% | 899,968 | +28.3% | 0.00% | -33.3% |
| Q3 2021 | $4,334,000 | +19.9% | 701,275 | +27.8% | 0.00% | +50.0% |
| Q2 2021 | $3,616,000 | +438.9% | 548,685 | +499.0% | 0.00% | – |
| Q1 2021 | $671,000 | +37.5% | 91,601 | +8.2% | 0.00% | – |
| Q4 2020 | $488,000 | -20.1% | 84,627 | -28.7% | 0.00% | -100.0% |
| Q2 2020 | $611,000 | – | 118,694 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AIGH Capital Management LLC | 1,986,176 | $12,275,000 | 2.58% |
| Worth Venture Partners, LLC | 454,364 | $2,808,000 | 1.26% |
| Opaleye Management Inc. | 455,600 | $2,816,000 | 0.53% |
| J. Goldman & Co LP | 1,663,229 | $10,279,000 | 0.52% |
| X-Square Capital, LLC | 92,283 | $570,000 | 0.30% |
| NEA Management Company, LLC | 3,952,958 | $24,429,000 | 0.29% |
| Birchview Capital, LP | 40,000 | $247,000 | 0.17% |
| PERSONAL CFO SOLUTIONS, LLC | 23,000 | $142,000 | 0.03% |
| PURA VIDA INVESTMENTS, LLC | 147,574 | $912,000 | 0.03% |
| GSA CAPITAL PARTNERS LLP | 35,232 | $218,000 | 0.02% |